Recombinant human thrombopoietin improves the efficacy of intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor in mobilizing peripheral blood stem cells in patients with multiple myeloma: A cohort study

The combination of intermediate-dose cyclophosphamide (ID-CTX) and granulocyte colony-stimulating factor (G-CSF) fails to mobilize peripheral blood stem cells (PBSCs) in approximately 20% of treated patients with multiple myeloma (MM). In this cohort study, patients with MM underwent PBSC mobilizati...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Guorong, Chen, Wenming, Wu, Yin, Li, Yanchen, Leng, Yun, Liu, Aijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815806/
https://www.ncbi.nlm.nih.gov/pubmed/29390394
http://dx.doi.org/10.1097/MD.0000000000009302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5815806/
https://www.ncbi.nlm.nih.gov/pubmed/29390394
http://dx.doi.org/10.1097/MD.0000000000009302

Ejemplares similares